Abstract

ObjectiveCongenital hypogonadotropic hypogonadism (CHH) and constitutional delay of growth and puberty (CDGP) represent rare and common forms of GnRH deficiency, respectively. Both CDGP and CHH present with delayed puberty, and the distinction between these two entities during early adolescence is challenging. More than 30 genes have been implicated in CHH, while the genetic basis of CDGP is poorly understood.DesignWe characterized and compared the genetic architectures of CHH and CDGP, to test the hypothesis of a shared genetic basis between these disorders.MethodsExome sequencing data were used to identify rare variants in known genes in CHH (n = 116), CDGP (n = 72) and control cohorts (n = 36 874 ExAC and n = 405 CoLaus).ResultsMutations in at least one CHH gene were found in 51% of CHH probands, which is significantly higher than in CDGP (7%, P = 7.6 × 10−11) or controls (18%, P = 5.5 × 10−12). Similarly, oligogenicity (defined as mutations in more than one gene) was common in CHH patients (15%) relative to CDGP (1.4%, P = 0.002) and controls (2%, P = 6.4 × 10−7).ConclusionsOur data suggest that CDGP and CHH have distinct genetic profiles, and this finding may facilitate the differential diagnosis in patients presenting with delayed puberty.

Highlights

  • Congenital hypogonadotropic hypogonadism (CHH (MIM: 146110)) is a rare disorder affecting approximately 1 in 4000 births (1)

  • Our data suggest that congenital delay of growth and puberty (CDGP) and CHH have distinct genetic profiles, and this finding may facilitate the differential diagnosis in patients presenting with delayed puberty

  • We found a large number of CHH patients (19/116, 16.4%) harboring putative IGSF10 mutations compared to CDGP (8/72, 11.1%) (Fig. 1A, B, C and D)

Read more

Summary

Introduction

Congenital hypogonadotropic hypogonadism (CHH (MIM: 146110)) is a rare disorder affecting approximately 1 in 4000 births (1). It is caused by GnRH deficiency, and subsequently results in altered activation of the hypothalamic–pituitary–gonadal (HPG) axis that controls sexual maturation and fertility. CHH presents as absent/incomplete puberty and infertility. In the presence of anosmia (the inability to smell) in approximately 50% of CHH probands, the condition is termed Kallmann syndrome (KS (MIM: 308700)). Other associated phenotypes such as hearing loss, synkinesia, renal agenesis, ataxia and cleft lip/palate are observed with variable frequency (2). In contrast to CHH, CDGP is a common disease, observed in 2–2.5% of the population (5)

Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call